Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Dec 5;13(6):635-6.
doi: 10.1016/j.stem.2013.11.017.

Inducing cellular aging: enabling neurodegeneration-in-a-dish

Affiliations
Comment

Inducing cellular aging: enabling neurodegeneration-in-a-dish

Kristen J Brennand. Cell Stem Cell. .

Abstract

The immaturity of neurons differentiated from human induced pluripotent stem cells (hiPSCs) presents difficulties for modeling late-onset neurodegenerative disorders such as Parkinson's disease. Now, Miller et al. (2013) provide a strategy for inducing aging-related phenotypes in hiPSC-derived neurons, enabling in vitro study of late-onset neurodegenerative diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Progerin-induced cellular aging.
Ectopic expression of just one factor, progerin, is sufficient to restore cellular and molecular markers of aging in patient fibroblasts, following re-differentiation from induced pluripotent stem cells. In addition, progerin expression partially infers an “old” identity to hiPSC-derived neurons, transforming them into an ideal platform for the in vitro study of age-related neurodegenerative disorders.

Comment on

  • Human iPSC-based modeling of late-onset disease via progerin-induced aging.
    Miller JD, Ganat YM, Kishinevsky S, Bowman RL, Liu B, Tu EY, Mandal PK, Vera E, Shim JW, Kriks S, Taldone T, Fusaki N, Tomishima MJ, Krainc D, Milner TA, Rossi DJ, Studer L. Miller JD, et al. Cell Stem Cell. 2013 Dec 5;13(6):691-705. doi: 10.1016/j.stem.2013.11.006. Cell Stem Cell. 2013. PMID: 24315443 Free PMC article.

References

    1. Byers B, Cord B, Nguyen HN, Schule B, Fenno L, Lee PC, Deisseroth K, Langston JW, Pera RR, Palmer TD. SNCA triplication Parkinson’s patient’s iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress. PLoS One. 2011;6:e26159. - PMC - PubMed
    1. Chung CY, Khurana V, Auluck PK, Tardiff DF, Mazzulli JR, Soldner F, Baru V, Lou Y, Freyzon Y, Cho S, et al. Identification and Rescue of alpha-Synuclein Toxicity in Parkinson Patient-Derived Neurons. Science. 2013 - PMC - PubMed
    1. Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, Boscolo FS, et al. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells. Nature. 2012;482:216–220. - PMC - PubMed
    1. Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Imamura K, Egawa N, Yahata N, Okita K, et al. Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness. Cell Stem Cell. 2013;12:487–496. - PubMed
    1. Liu GH, Qu J, Suzuki K, Nivet E, Li M, Montserrat N, Yi F, Xu X, Ruiz S, Zhang W, et al. Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature. 2012;491:603–607. - PMC - PubMed